Enzyme Tunnels and Gates As Relevant Targets in Drug Design
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Many enzymes contain tunnels and gates that are essential to their function. Gates reversibly switch between open and closed conformations and thereby control the traffic of small molecules—substrates, products, ions, and solvent molecules—into and out of the enzyme's structure via molecular tunnels. Many transient tunnels and gates undoubtedly remain to be identified, and their functional roles and utility as potential drug targets have received comparatively little attention. Here, we describe a set of general concepts relating to the structural properties, function, and classification of these interesting structural features. In addition, we highlight the potential of enzyme tunnels and gates as targets for the binding of small molecules. The different types of binding that are possible and the potential pharmacological benefits of such targeting are discussed. Twelve examples of ligands bound to the tunnels and/or gates of clinically relevant enzymes are used to illustrate the different binding modes and to explain some new strategies for drug design. Such strategies could potentially help to overcome some of the problems facing medicinal chemists and lead to the discovery of more effective drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
An open and closed case for all polymerases
Doublié, S., Sawaya, M. R., & Ellenberger, T. (1999) · Structure · doi:10.1016/s0969-2126(99)80017-3 · Cited by 314
Targeting aspartate aminotransferase in breast cancer
Thornburg, J. M., Nelson, K. K., Clem, B. F., Lane, A. N., Arumugam, S., Simmons, A., Eaton, J. W., Telang, S., & Chesney, J. (2008) · Breast Cancer Research · doi:10.1186/bcr2154 · Cited by 288
Marek, M., Kannan, S., Hauser, A.-T., Moraes Mourão, M., Caby, S., Cura, V., Stolfa, D. A., Schmidtkunz, K., Lancelot, J., Andrade, L., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003645 · Cited by 173
The Cluster of Hydrophobic Residues Controls the Entrance to the Active Site of Choline Oxidase
Xin, Y., Gadda, G., & Hamelberg, D. (2009) · Biochemistry · doi:10.1021/bi901295a · Cited by 33
Cited by
Jurcik, A., Bednar, D., Byska, J., Marques, S. M., Furmanova, K., Daniel, L., Kokkonen, P., Brezovsky, J., Strnad, O., Stourac, J., et al. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty386 · Cited by 393
Self-citationCaver Web 1.0: identification of tunnels and channels in proteins and analysis of ligand transport
Stourac, J., Vavra, O., Kokkonen, P., Filipovic, J., Pinto, G., Brezovsky, J., Damborsky, J., & Bednar, D. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz378 · Cited by 267
Self-citationLagerman, C. E., Grover, M. A., Rousseau, R. W., & Bommarius, A. S. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.131816 · Cited by 11
Roy, S., Roy, S., Mahata, B., Pramanik, J., Hennrich, M. L., Gavin, A.-C., & Teichmann, S. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1229703 · Cited by 5
WatCon: A Python Tool for Analysis of Conserved Water Networks Across Protein Families
Brownless, A.-L. R., Harrison-Rawn, T., & Kamerlin, S. C. L. (2025) · JACS Au · doi:10.1021/jacsau.5c00447 · Cited by 2
Metadata
- Authors
- Marques, S. M., Daniel, L., Buryska, T., Prokop, Z., Brezovsky, J., & Damborsky, J.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2016-12-13
- Volume
- 37
- Issue
- 5
- Pages
- 1095-1139
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2561607416
- Cited by
- 98
- References
- 5
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.